Gastroenterology
Volume 138, Issue 2 , Pages 583-594, February 2010

Inhibition of HDAC9 Increases T Regulatory Cell Function and Prevents Colitis in Mice

  • Edwin F. de Zoeten

      Affiliations

    • Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania
  • ,
  • Liqing Wang

      Affiliations

    • Division of Transplantation Immunology, Department of Pathology and Laboratory Medicine, and Biesecker Center for Pediatric Liver Diseases, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania
  • ,
  • Hong Sai

      Affiliations

    • Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania
  • ,
  • Wolfgang H. Dillmann

      Affiliations

    • Division of Endocrinology/Metabolism, University of California, San Diego, La Jolla, California
  • ,
  • Wayne W. Hancock

      Affiliations

    • Division of Transplantation Immunology, Department of Pathology and Laboratory Medicine, and Biesecker Center for Pediatric Liver Diseases, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania
    • Corresponding Author InformationReprint requests Address requests for reprints to: Wayne W. Hancock, Division of Transplantation Immunology, Pathology and Laboratory Medicine, 916B Abramson Research Center, The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104-4318. fax: (215) 590-7384

Received 23 February 2009; accepted 20 October 2009. published online 30 October 2009.

Background & Aims

Foxp3+ T regulatory cells (Tregs) help prevent autoimmunity, and increases in their numbers of functions could decrease the development of inflammatory bowel disease. Like other cells, Foxp3+ Tregs express histone/protein deacetylases (HDACs), which regulate chromatin remodeling and gene expression. We investigated whether disruption of a specific class IIa HDAC, HDAC9, activity in Tregs affects the pathogenesis of colitis in mice.

Methods

We tested the effects of various HDAC inhibitors (HDACi) in models of colitis using wild-type mice. We also transferred Tregs and non-Treg cells from HDAC9−/− or wild-type mice to immunodeficient mice. HDAC9 contributions to the functions of Tregs were determined during development and progression of colitis.

Results

Pan-HDACi, but not class I-specific HDACi, increased the functions of Foxp3+ Tregs, prevented colitis, and reduced established colitis in mice, indicating the role of class II HDACs in controlling Treg function. The abilities of pan-HDACi to prevent/reduce colitis were associated with increased numbers of Foxp3+ Tregs and their suppressive functions. Colitis was associated with increased local expression of HDAC9; HDAC9−/− mice resistant to development of colitis. HDAC9−/− Tregs expressed increased levels of the heat shock protein (HSP) 70, compared with controls. Immunoprecipitation experiments indicated an interaction between HSP70 and Foxp3. Inhibition of HSP70 reduced the suppressive functions of HDAC9−/− Tregs; Tregs that overexpressed HSP70 had increased suppressive functions.

Conclusions

Strategies to decrease HDAC9 expression or function in Tregs or to increase expression of HSP70 might be used to treat colitis and other autoimmune disorders.

Abbreviations used in this paper: CFSE, carboxyfluoroscein succinimidyl ester, HDAC, histone/protein deacetylase, HDACi, HDAC inhibitor, HSP, heat shock protein, IBD, inflammatory bowel disease, pPCR, quantitative polymerase chain reaction, SAHA, suberoylanilide hydroxamic acid, siRNA, small inhibitory RNA, Treg, T regulatory cell, TsA, Trichostatin-A

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the National Institutes of Health grants K08DK080189 (to E.F.d.Z.), R01AI073938 and P01AI073489 (to W.W.H.), and CDNHNF/NASPGHAN Fellow to Faculty Grant (to E.F.d.Z.).

PII: S0016-5085(09)01934-9

doi:10.1053/j.gastro.2009.10.037

Gastroenterology
Volume 138, Issue 2 , Pages 583-594, February 2010